Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02368951 |
Title | Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Bayer |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
San Francisco | California | 94115 | United States | Details | ||
Santa Monica | California | 90404-1200 | United States | Details | ||
New Haven | Connecticut | 06520 | United States | Details | ||
Chicago | Illinois | 60611 | United States | Details | ||
Baltimore | Maryland | 21231 | United States | Details | ||
Saint Louis | Missouri | 63110 | United States | Details | ||
New York | New York | 10016 | United States | Details | ||
Nashville | Tennessee | 37232 | United States | Details | ||
Houston | Texas | 77030 | United States | Details | ||
Seattle | Washington | 98109-1023 | United States | Details | ||
Seoul | 03080 | Korea, Republic of | Details | |||
Seoul | 138-736 | Korea, Republic of | Details | |||
Singapore | 169610 | Singapore | Details |